Skip to main content
Erschienen in: World Journal of Surgery 6/2010

01.06.2010

Normalization of 2-Week Postoperative Parathyroid Hormone Values in Patients with Primary Hyperparathyroidism: Four-Gland Exploration Compared to Focused-Approach Surgery

verfasst von: Peter J. Mazzaglia, Mira Milas, Eren Berber, Alan Siperstein, Jack M. Monchik

Erschienen in: World Journal of Surgery | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Elevation of parathyroid hormone (PTH) levels is commonly seen in patients with primary hyperparathyroidism (PHPT) who have undergone parathyroidectomy. This study evaluates differences in 2-week postoperative PTH levels in patients having focused-approach surgery versus four-gland exploration.

Methods

Over 6 years, patients at Rhode Island Hospital (RIH) and the Cleveland Clinic (CCF) who had PHPT and underwent localization studies suggestive of single adenoma were analyzed. At RIH patients underwent focused-approach surgery, and at CCF routine four-gland exploration was performed. Postoperative calcium supplementation was routine at RIH and selective at CCF.

Results

There were 308 patients at RIH and 370 at CCF. They were similar in age (59.2 ± 13.0 years at RIH and 60.4 ± 12.9 years at CCF), and sex (76.9 and 80.0% female at RIH and CCF, respectively). The mean preoperative serum calcium measured 10.9 ± 0.7 mg/dl at RIH and 11.1 ± 0.7 mg/dl at CCF (P < 0.001). Preoperative PTH values were similar, measuring 143.8 ± 104.8 pg/ml in the focused-approach group (RIH) and 157.6 ± 150.3 pg/ml in the four-gland exploration group (CCF). Preoperative 25-hydroxyvitamin D (vitamin D-25) levels were 24.1 ± 12.0 ng/ml at RIH and 27.4 ± 10.6 ng/ml at CCF; and the prevalence of vitamin D-25 deficiency (level <20 ng/ml) was 43.9% at RIH and 27% at CCF (P = 0.017). The proportion of patients whose intraoperative PTH value dropped by ≥50% prior to completion of surgery was 95.0% at RIH and 95.5% at CCF. The total gland weight resected per patient was 942 mg at RIH versus 1,394 mg at CCF (P = 0.003). The 2-week postoperative serum PTH was >65 pg/ml in 18.8% at RIH and in 38.7% at CCF (P < 0.001). The 2-week postoperative serum calcium values dropped to 9.2 ± 0.6 mg/dl at RIH and to 9.5 ± 0.8 mg/dl at CCF (P < 0.001). The incidence of multigland disease was 5.8% at RIH and 21.9% at CCF (P ≤ 0.001).

Conclusions

Among patients with PHPT who underwent a localizing study indicating unilateral disease, a significant proportion had eucalcemic PTH elevation 2 weeks after parathyroidectomy. The elevation was more frequent in the four-gland exploration group and correlated most strongly with greater adenoma mass.
Literatur
1.
Zurück zum Zitat Wermers RA, Khosla S, Atkinson EJ et al (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440PubMed Wermers RA, Khosla S, Atkinson EJ et al (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440PubMed
2.
Zurück zum Zitat DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251–1262PubMed DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251–1262PubMed
3.
Zurück zum Zitat Mazzaglia PJ, Berber E, Kovach A et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143:260–266CrossRefPubMed Mazzaglia PJ, Berber E, Kovach A et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143:260–266CrossRefPubMed
4.
Zurück zum Zitat Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518 (discussion 518–519)CrossRefPubMed Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518 (discussion 518–519)CrossRefPubMed
5.
Zurück zum Zitat Chan AK, Duh QY, Katz MH et al (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg 222:402–412 (discussion 412–414)CrossRefPubMed Chan AK, Duh QY, Katz MH et al (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg 222:402–412 (discussion 412–414)CrossRefPubMed
6.
Zurück zum Zitat Siperstein AE, Shen W, Chan AK et al (1992) Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1163) Siperstein AE, Shen W, Chan AK et al (1992) Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1163)
7.
Zurück zum Zitat Irvin GL III, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302CrossRefPubMed Irvin GL III, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302CrossRefPubMed
8.
Zurück zum Zitat Siperstein A, Berber E, Mackey R et al (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880CrossRefPubMed Siperstein A, Berber E, Mackey R et al (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880CrossRefPubMed
9.
Zurück zum Zitat Irvin GL III, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708 (discussion 708–711)CrossRefPubMed Irvin GL III, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708 (discussion 708–711)CrossRefPubMed
10.
Zurück zum Zitat Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–670 (discussion 670–672)CrossRefPubMed Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–670 (discussion 670–672)CrossRefPubMed
11.
Zurück zum Zitat Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478 (discussion 478–479)CrossRefPubMed Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478 (discussion 478–479)CrossRefPubMed
12.
Zurück zum Zitat Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692CrossRefPubMed Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692CrossRefPubMed
13.
Zurück zum Zitat Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317CrossRefPubMed Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317CrossRefPubMed
14.
Zurück zum Zitat Carneiro DM, Solorzano CC, Irvin GL III (2004) Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 199:849–853 (discussion 853–855)CrossRefPubMed Carneiro DM, Solorzano CC, Irvin GL III (2004) Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 199:849–853 (discussion 853–855)CrossRefPubMed
15.
Zurück zum Zitat Beyer TD, Solorzano CC, Prinz RA et al (2007) Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141:777–783CrossRefPubMed Beyer TD, Solorzano CC, Prinz RA et al (2007) Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141:777–783CrossRefPubMed
16.
Zurück zum Zitat Duh QY, Arnaud CD, Levin KE et al (1986) Parathyroid hormone: before and after parathyroidectomy. Surgery 100:1021–1031PubMed Duh QY, Arnaud CD, Levin KE et al (1986) Parathyroid hormone: before and after parathyroidectomy. Surgery 100:1021–1031PubMed
17.
Zurück zum Zitat Irvin GL III, Newell DJ, Morgan SD (1987) Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism. Surgery 102:898–902PubMed Irvin GL III, Newell DJ, Morgan SD (1987) Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism. Surgery 102:898–902PubMed
18.
Zurück zum Zitat Bergenfelz A, Valdemarsson S, Tibblin S (1996) Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease. Surgery 119:624–633CrossRefPubMed Bergenfelz A, Valdemarsson S, Tibblin S (1996) Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease. Surgery 119:624–633CrossRefPubMed
19.
Zurück zum Zitat Yen TW, Wilson SD, Krzywda EA et al (2006) The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140:665–672 (discussion 672–674)CrossRefPubMed Yen TW, Wilson SD, Krzywda EA et al (2006) The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140:665–672 (discussion 672–674)CrossRefPubMed
20.
Zurück zum Zitat Carty SE, Roberts MM, Virji MA et al (2002) Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 132:1086–1092 (discussion 1092–1093)CrossRefPubMed Carty SE, Roberts MM, Virji MA et al (2002) Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 132:1086–1092 (discussion 1092–1093)CrossRefPubMed
21.
Zurück zum Zitat Stewart ZA, Blackford A, Somervell H et al (2005) 25-Hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138:1018–1025 (discussion 1025–1026)CrossRefPubMed Stewart ZA, Blackford A, Somervell H et al (2005) 25-Hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138:1018–1025 (discussion 1025–1026)CrossRefPubMed
22.
Zurück zum Zitat Denizot A, Pucini M, Chagnaud C et al (2001) Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 182:15–19CrossRefPubMed Denizot A, Pucini M, Chagnaud C et al (2001) Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 182:15–19CrossRefPubMed
23.
Zurück zum Zitat Nordenstrom E, Westerdahl J, Isaksson A et al (2003) Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg 27:212–215PubMed Nordenstrom E, Westerdahl J, Isaksson A et al (2003) Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg 27:212–215PubMed
24.
Zurück zum Zitat Picton ML, Moore PR, Mawer EB et al (2000) Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440–1449CrossRefPubMed Picton ML, Moore PR, Mawer EB et al (2000) Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440–1449CrossRefPubMed
25.
Zurück zum Zitat Yamashita H, Noguchi S, Moriyama T et al (2005) Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity. Surgery 137:419–425CrossRefPubMed Yamashita H, Noguchi S, Moriyama T et al (2005) Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity. Surgery 137:419–425CrossRefPubMed
26.
Zurück zum Zitat Mittendorf EA, McHenry CR (2002) Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 128:275–279PubMed Mittendorf EA, McHenry CR (2002) Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 128:275–279PubMed
27.
Zurück zum Zitat Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70:114–119 (discussion 119–120)PubMed Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70:114–119 (discussion 119–120)PubMed
28.
Zurück zum Zitat Westerdahl J, Lindblom P, Valdemarsson S et al (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135:142–147CrossRefPubMed Westerdahl J, Lindblom P, Valdemarsson S et al (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135:142–147CrossRefPubMed
29.
Zurück zum Zitat Westerdahl J, Valdemarsson S, Lindblom P et al (2000) Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg 24:1323–1329CrossRefPubMed Westerdahl J, Valdemarsson S, Lindblom P et al (2000) Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg 24:1323–1329CrossRefPubMed
30.
Zurück zum Zitat Harvey A, Barbosa-Hernandez G, Walks N, et al (2008) Parathyroid tumor burden is a critical mass of parathyroid tissue necessary for manifestations of primary hyperparathyroidism. Soc Surg Oncol Harvey A, Barbosa-Hernandez G, Walks N, et al (2008) Parathyroid tumor burden is a critical mass of parathyroid tissue necessary for manifestations of primary hyperparathyroidism. Soc Surg Oncol
31.
Zurück zum Zitat Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551CrossRefPubMed Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551CrossRefPubMed
32.
Zurück zum Zitat Siperstein A, Berber E, Barbosa GF et al (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428PubMed Siperstein A, Berber E, Barbosa GF et al (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428PubMed
Metadaten
Titel
Normalization of 2-Week Postoperative Parathyroid Hormone Values in Patients with Primary Hyperparathyroidism: Four-Gland Exploration Compared to Focused-Approach Surgery
verfasst von
Peter J. Mazzaglia
Mira Milas
Eren Berber
Alan Siperstein
Jack M. Monchik
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 6/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0557-6

Weitere Artikel der Ausgabe 6/2010

World Journal of Surgery 6/2010 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.